E. Carmack Holmes, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 3,000 shares at $3.15 ($9K) on 2011-08-19, disclosed to the SEC on 2011-08-23.
Open-market purchase of $9k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.